Activation of GPR35 has been shown to reduce weight gain and fat accumulation in metabolic disorders such as obesity and type 2 diabetes, suggesting its relevance to lipid metabolism (3). This evidence concerns the gene GPR35 and type 2 diabetes mellitus.